Elaborating on this weight-loss innovation, Dr Nik Ritza Kosai said there are various types of IGBs but only the Allurion balloon does not require an endoscopy for insertion. "All a patient has to ...

Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back on sale in the country. In August 2024, the US company agreed to ...

Reports Q4 revenue $5.6M, compared to $8.2M for the same period in 2023. The year-over-year decrease in revenue was primarily due to the ...

Chardan notes that Allurion has announced additional data evaluating the use of its Allurion Balloon in combination with patients be treated ...

"I believe combining the Allurion Balloon with low-dose GLP-1 therapy ... case series and is expected to be presented at upcoming medical meetings.

Allurion Technologies ... loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is ...

ALUR), a medical device company with a market capitalization of $17.7 million focused on addressing obesity, announced today its plan to conduct a clinical study on the combined use of the Allurion ...

Microcap Allurion Technologies (NYSE:ALUR) surged ~31% in after-hours trading Thursday after posting preliminary data on weight loss associated with its gastric balloon in combination with Novo ...

The study will focus on combination use of the Allurion Balloon with lower dose GLP-1s with the goal of demonstrating improved long-term tolerability and adherence to GLP-1 therapy. Previous ...

“I believe combining the Allurion Balloon with low-dose GLP-1 therapy ... case series and is expected to be presented at upcoming medical meetings. Allurion is dedicated to ending obesity.